286 The presence of aberrant myeloid progenitors predicts overall survival in intermediate-2 and high risk myelodysplastic syndromes upon treatment with azacitidine
C. Alhan; T.M. Westers; C. Eeltink; C. Cali; G. Huls; G.J. Ossenkoppele; A.A. van de Loosdrecht
- 作者C. Alhan; T.M. Westers; C. Eeltink; C. Cali; G. Huls; G.J. Ossenkoppele; A.A. van de Loosdrecht
- 卷第35卷
- 印刷ISSN0145-2126
- 文件大小51.34KB
- 发表时间2011
- DOI10.1016/s0145-2126(11)70288-0